Prospective Randomized Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate.
Phase of Trial: Phase IV
Latest Information Update: 28 Mar 2013
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 01 Mar 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Jan 2013 New source identified and integrated (Mayo Clinic; 11-004589).
- 10 Jan 2013 Planned End Date changed from 1 May 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.